Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALStandard

INTRAROSA

PRASTERONE

Standard Dose
6.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview INTRAROSA is listed in Drugs@FDA under application 208470 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PRASTERONE Form and strength INSERT;VAGINAL - 6.5MG Sponsor MILLICENT Submission history Latest submission status date: 2018-02-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview INTRAROSA is listed in Drugs@FDA under application 208470 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PRASTERONE Form and strength INSERT;VAGINAL - 6.5MG Sponsor MILLICENT Submission history Latest submission status date: 2018-02-13 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
INTRAROSA (PRASTERONE) | Drug Monograph | MedicHelpline